Topically applied formulations certified as medicals devices (not topical drugs or medicines) play increasingly vital roles in the management of challenging or chronic dermatologic conditions. These adjunctive formulations must be manufactured under stringent regulatory requirements to the highest quality standards, although, compared with drugs, the marketing authorisation process may be less complex.